Blockade of CXCR4 can inhibit the activation of CXCR4 after binding with CXCL12 and regulate autophagy through the PI3K/AKT/mTOR pathway to improve and reduce atherosclerosis and improve cardiac structure. Here, CXCR4 is linked to atherosclerosis.